VALNEVA Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate
Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate Saint-Herblain (France), December 21, 2018 - Valneva SE ("Valneva"), a biotech company developing and commercializing vaccines for infectious diseases with major unmet …